Modulation of the Surgical Stress Response in the Early Postoperative Period After Radical Nephrectomy as the Core of the Nephroprotective Strategy

Background: One of the most important problems in medicine today is prevention of chronic kidney disease development and progression in patients who underwent radical nephrectomy. Surgical removal of one kidney initiates adaptive functional and morphological restructuring in the other one. Changes in the condition of the remaining kidney have been sufficiently detailed, whereas systemic metabolic disorders induced by surgical stress, which occur during remodeling of the kidney parenchyma and functional restructuring of the kidney, remain overlooked. Both local processes of recovery, adaptation, and compensation in the remaining kidney and the endocrine and metabolic response as a whole should be examined. Only adequate pharmacological modulation of the endocrine-metabolic stress response to surgery will contribute to providing optimal conditions for proper anatomical and functional adaptation of the remaining kidney and preventing kidney diseases.

Objective: To justify an algorithm for patient management in the early postoperative period after radical nephrectomy that minimizes risks of dysfunction of the remaining kidney.

Materials and methods: We examined 2 groups of patients who underwent radical nephrectomy, one of which additionally received a synthetic adaptogen, Selank, for 2 weeks after the surgery.

Results: The patients additionally receiving Selank had significantly better results in terms of the dynamics of recovery initiated by surgery: disorders of biogenic amine metabolism, psycho-emotional disorders, vegetative-vascular disorders, and glomerular filtration rates.

Conclusions: The surgery is a strong stressor that disrupts adaptive mechanisms both at systemic and organ levels. The combination of these pathological processes ultimately results in an overload of the compensatory capabilities of the remaining kidney, which requires pharmacological support from day 1 after surgery. Given the mechanism of disrupted adaptive reactivity due to neuro-endocrine regulation disorders, synthetic adaptogens based on regulatory peptides may be the best solution.

1. Can O, Sabuncu K, Erkoç M, et al. Chronic kidney disease following nephrectomy for renal tumours: retrospective analysis risk factors. African Journal of Urology. 2023;29:42. https://doi.org/10.1186/s12301-023-00373-3

2. Frolova VE, Maximov AYu, Demidova AA, Agarkova EI. Prediction of chronic renal failure after nephrectomia in patients with kidney cancer. Sovremennye problemy nauki i obrazovaniya. 2011;(6). (In Russ.).

3. Kogan MI, Gusev AA, Evseyev SV. Evaluation of renal function in patients with renal cell carcinoma before and after radical nephrectomy. Cancer Urology. 2011;(4):16–20. (In Russ.).

4. Andreev SS, Tityaev II, Neymark BA, Vasilenko AA. Early signs of single kidney dysfunction after nephrectomy for kidney cancer. Ural Medical Journal. 2022;21(4):13–18. (In Russ.).

5. Tiuzikov IA, Grekov EA, Martov AG. Diseases of solitary kidney: the history and evolution of scientific issues. Urologiia. 2013;(6):103–110. (In Russ.). PMID: 24649775.

6. Gerzenberg GI. Immediate and long-term nephrectomy outcomes. Vestnik khirurgii. 1936;(48):33. (In Russ.).

7. Ivanov AP, Tyuzikov IA. Nephrectomy in modern conditions: the reasons and further destiny of the patients with a solitary kidney. The Fundamental Researches. 2011;(7):64–66. (In Russ.).

8. Yanbarisova EV, Gilmutdinov AR. Recovery therapy for patients after nephrectomy. Advances in Current Natural Sciences. 2014;(6):76–78. (In Russ.).

9. Volkova MI, Skvortsov IYa, Klimov AV, et al. Impact of surgical volume on functional results and cardiospecific survival rates in patients with clinically localized renal cancer. Cancer Urology. 2014;(3):22–30. (In Russ.).

10. Ivashchenko VV, Chernyshev IV, Ivashchenko AV, Kalabekov AA, Grebenkin MV. Sanogenesis, adaptation, and medicine in urology. Surgical Practice. 2017;(1):29–32. (In Russ.).

11. Tyuzikov IA, Ivanov AP. New pathogenic mechanisms of a solitary kidney diseases. The Fundamental Researches. 2011;(11– 2):366–368. (In Russ.).

12. Sal’nikov YeV, Kostin AA, Kuz’min AF, Fateyev DM. Influence of nephrectomy and kidney resections on the exchange of catecholamines in blood in sick of kidney cancer. Vestnik Kostromskogo gosudarstvennogo universiteta im. N.A. Nekrasova. 2012;18(5):18–21. (In Russ.).

13. Tityaev II, Andreev SS, Andreeva SV, Udalov KV, Kasyanov DS. Hypertensive nephropathy as an outcome of unilateral nephrectomy for kidney cancer. Urology Reports (St. Petersburg). 2020;10(3):229– 234. (In Russ.). https://doi.org/10.17816/uroved42529

14. Markova TP. Immunotropic drugs and adaptogens. RMJ. 2019;27(8–1):60–64. (In Russ.).

15. Khavinson VKh. Peptide medicines: past, present, future. Clinical Medicine (Russian Journal). 2020;98(3):165–177. (In Russ.). https://doi.org/10.30629/0023-2149-2020-98-3-165-177

16. V’yunova TV, Andreeva LA, Shevchenko KV, Shevchenko VP, Myasoedov NF. Peptide regulation of specific ligand-receptor interactions of GABA with the plasma membranes of nerve cells. Neirokhimiya. 2014;31(4):300–306. (In Russ.). https://doi.org/10.7868/s1027813314040116

17. Goryachkovsky AM. Clinical Biochemistry in Laboratory Diagnostics. Ekologiya; 2005. (In Russ.).

18. Zung WWK. How Normal Is Anxiety? (Current Concepts). Upjohn; 1980.

19. Vaguine YuE, Deunezhewa SM, Khlytina AA. Kerdo vegetative index: role of initial parameters, areas and limitations of application. Fiziologiya cheloveka. 2021;47(1):31–42. (In Russ.). https://doi.org/10.31857/s0131164620060120

20. Jaffe M. Ueber den Niederschlag, welchen Pikrinsäure in normalem Harn erzeugt und über eine neue Reaction des Kreatinins. Zeitschrift für Physiologische Chemie. 1886;10(5):391–400. (In German). https://doi.org/10.1515/bchm1.1886.10.5.391

21. Smirnov AV, Dobrobravov VA, Kayukov IG, et al. Recommendations of the Research Institute of Nephrology of St.Petersburg Medical University named after I.P.Pavlov: definition, classification, diagnostics and main trends of prophylactics of chronic kidney disease in adults. Nephrology. 2008;12(2):75–93. (In Russ.).